[CK19 is associated with poor survival in patients with dual-phenotype hepatocellular carcinoma]

Zhonghua Gan Zang Bing Za Zhi. 2024 Nov 11:32:1-9. doi: 10.3760/cma.j.cn501113-20240307-00118. Online ahead of print.
[Article in Chinese]

Abstract

Objective: To study the role of CK19 in the survival of patients diagnosed with DPHCC in Fujian, China, which has a high incidence of hepatocellular carcinoma (HCC). Methods: Patients with DPHCC (n=84) who had undergone surgical interventions at the 900th Hospital of Joint Logistic Support Force between 2013 and 2019 were retrospectively analyzed using the log-rank test and Kaplan-Meier method. Univariate and multivariate Cox model analyses were also conducted to further understand the correlation between CK19 and patient survival. Results: (1)Tumor size, differentiation, peripheral hepatic fibrosis, liver capsule invasion, microvascular invasion (MVI) and serum CA-199 level showed a correlation with CK19, as per the outcomes of Chi-squared tests. (2)According to the univariate analysis, the expression of CK19, MVI, the number of tumor lesions, necrosis, differentiation, peripheral hepatic fibrosis, and serum levels of both alpha-fetoprotein (AFP) and CA-199 showed a strong correlation with overall survival. (3)Necrosis and serum AFP levels were strongly related to an increased risk of death, according to the multivariate analysis. Conclusions: The expression of CK19 may correlate with the survival of patients with DPHCC and could potentially serve as a prognostic predictor of survival.

目的: 探讨免疫组织化学标志物细胞角蛋白(CK)19的表达与双表型肝细胞癌(DPHCC)的临床特征及其预后的相关性。 方法: 收集确诊为肝细胞癌(HCC)并行外科手术切除的患者资料,通过免疫组织化学法筛选出DPHCC病例,并进行追踪随访及分组;采用统计学方法分析免疫组织化学标志物CK19的表达与DPHCC临床病理特征及其预后的相关性。计数资料组间比较采用χ2检验或Fisher确切概率法分析。 结果: CK19的表达与DPHCC的肿瘤大小、组织学分级、周围肝组织肝硬化、微血管侵犯(MVI)及血清中糖类抗原199(CA-199)水平等因素显著相关,差异具有统计学意义(P<0.05);与DPHCC患者的性别、年龄、肿瘤坏死、多发病灶、肝被膜侵犯、血清学甲胎蛋白(AFP)及免疫组织化学CK7、黏蛋白1(MUC-1)的表达等因素无明显相关,差异无明显统计学意义(P>0.05)。单因素分析结果显示:免疫组织化学CK19表达、MVI、病灶数量、肿瘤坏死、肿瘤分化程度及血清中AFP、糖类抗原199水平是影响DPHCC患者预后的相关因素(P<0.05);而性别、年龄、被膜侵犯、肿瘤大小及免疫组织化学标志物(血管内皮细胞生长因子、CK7、MUC-1)的表达与DPHCC患者预后无明显相关性(P>0.05)。多因素分析结果显示:肿瘤坏死(P=0.042,95%CI:1.031~5.501)、血清中AFP水平是(P<0.001,95%CI:2.581~24.075)影响DPHCC患者预后的独立危险因素。 结论: CK19的表达与DPHCC患者的预后密切相关,CK19高表达患者较CK19低表达患者疾病进展快;且CK19高表达患者总生存率显著低于CK19低表达患者,是DPHCC患者预后不良的危险因素。.

Publication types

  • English Abstract